Ligand Pharmaceuticals formed drug development partnerships with Amgen, Merck KGaA, and Pfizer.
Steady: 0 in the last 7 days
Updated oct 6
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ligand Pharmaceuticals formed drug development partnerships with Amgen, Merck KGaA, and Pfizer.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Ligand Pharmaceuticals funds drug development in partnership with Merck.Sub-event
- Ligand Pharmaceuticals appointed Todd Davis as CEO, acquired a 56% stake in Pelthos Therapeutics Inc., and secured royalty rights on ZELSUVMI sales.Sub-event
Ligand announced new drug development partnerships with three major pharmaceutical companies.1 source
Keep exploring
The entities involved
-
Ligand Pharmaceuticals
biopharmaceutical company based out of La Jolla, California
Nothing else this week.
-
Amgen
American multinational biopharmaceutical company
-
Merck KGaA
German multinational science and technology company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
Related events
Coverage
Newest first; wire copies grouped- dailypolitical.com
- GlobeNewswireLigand to Report Second Quarter 2025 Financial Results on August 7, 2025 JUPITER, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it wi